PRTK NASDAQ
Paratek Pharmaceuticals, Inc.
1W: +0.0%
1M: +1.4%
3M: +0.9%
1Y: -10.1%
3Y: -60.0%
5Y: -76.4%
$2.23
Last traded 2023-09-29 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$168M
Revenue
+66.0% YoY
$-67M
Net Income
+25.8% YoY
$-23M
Free Cash Flow
+14.3% YoY
88.5%
Gross Margin
-24.7%
Op. Margin
-38.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE38.3%
ROA-43.4%
ROIC-224.1%
Valuation
P/E-1.9
P/B-0.7
EV/EBITDA-7.9
Leverage
Debt/Equity-1.29
Current Ratio0.52
Interest Cov.-2.3x
Quality Scores
Piotroski F4/9
Altman Z-9.69
Beneish M-3.52